ArticleCancer research2015

RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Xuesong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.